|
Gene expression
Citations 21-30 of 245 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Effect of Olmesartan on Tissue Expression Balance Between Angiotensin II Receptor and Its Inhibitory Binding Molecule
- Atsu-ichiro Shigenaga, Kouichi Tamura, Hiromichi Wakui, Shin-ichiro Masuda, Koichi Azuma, Yuko Tsurumi-Ikeya, Motoko Ozawa, Masaki Mogi, Miyuki Matsuda, Kazuaki Uchino, Kazuo Kimura, Masatsugu Horiuchi, and Satoshi Umemura
Hypertension published August 25, 2008, doi:10.1161/HYPERTENSIONAHA.108.117341
[Abstract]
- Editorial Commentary
Characterization and Functional Analyses of the Human G Protein–Coupled Receptor Kinase 4 Gene Promoter
- Peter A. Doris
Hypertension published August 18, 2008, doi:10.1161/HYPERTENSIONAHA.108.116145
[Abstract]
- Scientific Contributions
Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats
- Amanda K. Sampson, Karen M. Moritz, Emma S. Jones, Rebecca L. Flower, Robert E. Widdop, and Kate M. Denton
Hypertension published August 18, 2008, doi:10.1161/HYPERTENSIONAHA.108.114058
[Abstract]
- Scientific Contributions
Modulation of Angiotensin II–Mediated Hypertension and Cardiac Remodeling by Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Deletion
- Changping Hu, Abhijit Dandapat, Liuqin Sun, Muhammad R. Marwali, Nobutaka Inoue, Fumiaki Sugawara, Kazuhiko Inoue, Yosuke Kawase, Kou-ichi Jishage, Hiroshi Suzuki, Paul L. Hermonat, Tatsuya Sawamura, and Jawahar L. Mehta
Hypertension published July 21, 2008, doi:10.1161/HYPERTENSIONAHA.108.115287
[Abstract]
- Original Articles
Hepatocyte Nuclear Factor 1 and Hypertensive Nephropathy
- Renata I. Dmitrieva, Cruz A. Hinojos, Eric Boerwinkle, Michael C. Braun, Myriam Fornage, and Peter A. Doris
Hypertension 2008;51:1583-1589; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110163
[Abstract]
[Full text]
- Original Articles
Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Sp1
- Ikuyo Imayama, Toshihiro Ichiki, Dan Patton, Keita Inanaga, Ryohei Miyazaki, Hideki Ohtsubo, Qingping Tian, Kotaro Yano, and Kenji Sunagawa
Hypertension 2008;51:1631-1636; published online before print as doi:10.1161/HYPERTENSIONAHA.107.106963
[Abstract]
[Full text]
- Original Articles
Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors
- Arvi Duka, Ekaterina Kintsurashvili, Irena Duka, Deborah Ona, Teresa A. Hopkins, Michael Bader, Irene Gavras, and Haralambos Gavras
Hypertension 2008;51:1352-1357; published online before print as doi:10.1161/HYPERTENSIONAHA.107.108506
[Abstract]
[Full text]
- Scientific Contributions
Hepatocyte Nuclear Factor 1 and Hypertensive Nephropathy
- Renata I. Dmitrieva, Cruz A. Hinojos, Eric Boerwinkle, Michael C. Braun, Myriam Fornage, and Peter A. Doris
Hypertension published April 28, 2008, doi:10.1161/HYPERTENSIONAHA.108.110163
[Abstract]
- Scientific Contributions
Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Sp1
- Ikuyo Imayama, Toshihiro Ichiki, Dan Patton, Keita Inanaga, Ryohei Miyazaki, Hideki Ohtsubo, Qingping Tian, Kotaro Yano, and Kenji Sunagawa
Hypertension published April 28, 2008, doi:10.1161/HYPERTENSIONAHA.107.106963
[Abstract]
- Original Articles
Interference With PPAR Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling
- Andreas M. Beyer, Gary L. Baumbach, Carmen M. Halabi, Mary L. Modrick, Cynthia M. Lynch, Thomas D. Gerhold, Shams M. Ghoneim, Willem J. de Lange, Henry L. Keen, Yau-Sheng Tsai, Nobuyo Maeda, Curt D. Sigmund, and Frank M. Faraci
Hypertension 2008;51:867-871; published online before print as doi:10.1161/HYPERTENSIONAHA.107.103648
[Abstract]
[Full text]
|
|
